» Articles » PMID: 14656418

How Reliable is the History of Chickenpox? Varicella Serology Among Children Up to 14 Years of Age

Overview
Publisher Elsevier
Date 2003 Dec 6
PMID 14656418
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to assess the seroprevalence of antibodies to varicella-zoster virus (VZV) in children of northern Greece and to estimate the reliability of varicella history.

Methods: A serosurvey of 632 children, aged 13 months to 14 years (median 5.2 years), was conducted between April 1999 and July 2001. Serum samples were tested by enzyme-linked immunosorbent assay (ELISA) for IgG antibodies to VZV (IgG Genzyme Virotech GmbH). A history of varicella in these children was obtained from the parents of all these patients. Also, a check of state health cards of the patients was done.

Results: Two hundred and forty-eight (39%) of the children were seropositive for VZV. Two hundred and thirty (36%) of the 632 children claimed to have had previous varicella infection; 87.8% were seropositive, and 12.2% lacked antibodies to VZV. One hundred and seven of the 230 children with a history of varicella had the information about the disease confirmed, as it was reported on their state health card by a pediatrician; 10.2% were seronegative for VZV. Absence of history of varicella was reported in 402 (63.6%) of the 632 children; 88.6% of those were seronegative, and 11.4% were seropositive. The percentage of incorrect negative history ranged from 6% (13-60 months of age) to 48% (120-168 months of age).

Conclusions: A large proportion of the study group (61%), mainly below 7 years of age, is susceptible to varicella. The positive predictive value of a history of varicella is 87.8%, whereas the negative predictive value of a negative history is 11.4%, which means that there is an 88.6% probability of a negative history being correct. Varicella serology may be reasonable prior to vaccination in children >10 years old with a negative chickenpox history. However, if one excludes cost considerations, it is also reasonable to vaccinate all children, irrespective of serostatus.

Citing Articles

Changes in epidemiological characteristics and sero-prevalence against the varicella zoster virus in school-age children after the introduction of a national immunization program in Japan.

Yasui Y, Mitsui T, Arima F, Uchida K, Inokuchi M, Tokumura M Hum Vaccin Immunother. 2021; 17(8):2494-2500.

PMID: 33650932 PMC: 8475580. DOI: 10.1080/21645515.2021.1890968.


Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization.

Riera-Montes M, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A BMC Infect Dis. 2017; 17(1):353.

PMID: 28521810 PMC: 5437534. DOI: 10.1186/s12879-017-2445-2.


Application of Oral Fluid Assays in Support of Mumps, Rubella and Varicella Control Programs.

Maple P Vaccines (Basel). 2015; 3(4):988-1003.

PMID: 26690230 PMC: 4693228. DOI: 10.3390/vaccines3040988.


Validity of a reported history of chickenpox in targeting varicella vaccination at susceptible adolescents in England.

Field N, Amirthalingam G, Waight P, Andrews N, Ladhani S, van Hoek A Vaccine. 2013; 32(10):1213-7.

PMID: 23871823 PMC: 3969712. DOI: 10.1016/j.vaccine.2013.06.098.


The vascular effects of infection in Pediatric Stroke (VIPS) Study.

Fullerton H, Elkind M, Barkovich A, Glaser C, Glidden D, Hills N J Child Neurol. 2011; 26(9):1101-10.

PMID: 21616922 PMC: 3397827. DOI: 10.1177/0883073811408089.